Concepedia

Suzan Lazo-Kallanian

SL

Statistics

Publications

6

Citations

1.9K

H-Index

6

Active since

1999

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Novartis (Switzerland)

Massachusetts General Hospital

Suzan Lazo-Kallanian is an author at Dana-Farber Cancer Institute specializing in hematology, life sciences, and medicine.

Publications per year

1999–2015

6

Publications

6

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

Zuzana Tóthová, Ramya Kollipara, Brian J.P. Huntly et al. · Cell · 2007 · 1.5K citations · Full text

Life Sciences, Cell Biology, Hematology +16

Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenström macroglobulinemia

Anne-Sophie Moreau, Xiaoying Jia, Hai T. Ngo et al. · Blood · 2007 · 98 citations · Full text

Medicine, Oncology, Pharmacology +9

Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level

Vivienne I. Rebel, Sheila Hartnett, Geoffrey R. Hill et al. · The Journal of Experimental Medicine · 1999 · 90 citations

Life Sciences, Cell Biology, Hematology +17

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Rao Prabhala, Mariateresa Fulciniti, Dheeraj Pelluru et al. · Leukemia · 2015 · 75 citations · Full text

Medicine, Hematology, Immunology +14

Up-Regulation of α4β7 Integrin on Peripheral T Cell Subsets Correlates with the Development of Acute Intestinal Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation

Yi‐Bin Chen, Haesook T. Kim, Sean M. McDonough et al. · Biology of Blood and Marrow Transplantation · 2009 · 54 citations · Full text

Life Sciences, Immunology, Pathology +16

1–5 of 6